Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating in Vivo AZA Incorporation in Mononuclear Cells Following Vidaza or CC486

NCT03493646 is registered in ClinicalTrials.gov with Kirby Institute as lead sponsor.

NCT NCT03493646
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03493646 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating in Vivo AZA Incorporation in Mononuclear Cells Following Vidaza or CC486
Lead sponsor
Kirby Institute
Phase
Phase 2
Overall status
Completed
Start date
May 18, 2018
Completion date
September 21, 2021
Enrollment
40 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia, chronic myelomonocytic leukemia, myelodysplastic syndromes